Research Burden of Interstitial Lung Diseases in Turkey - RBILD
- PMID: 35494165
- PMCID: PMC9007027
- DOI: 10.36141/svdld.v39i1.12269
Research Burden of Interstitial Lung Diseases in Turkey - RBILD
Abstract
Introduction: The aim of our study is to investigate the etiological distribution of ILD in Turkey by stratifying the epidemiological characteristics of ILD cases, and the direct cost of initial diagnosis of the diagnosed patients.
Material-method: The study was conducted as a multicenter, prospective, cross-sectional, clinical observation study. Patients over the age of 18 and who accepted to participate to the study were included and evaluated as considered to be ILD. The findings of diagnosis, examination and treatment carried out by the centers in accordance with routine diagnostic procedures were recorded observationally.
Results: In total,1070 patients were included in this study. 567 (53%) of the patients were male and 503 (47%) were female. The most frequently diagnosed disease was IPF (30.5%). Dyspnea (75.9%) was the highest incidence among the presenting symptoms. Physical examination found bibasilar inspiratory crackles in 56.2 % and radiological findings included reticular opacities and interlobular septal thickenings in 55.9 % of the cases. It was observed that clinical and radiological findings were used most frequently (74.9%) as a diagnostic tool. While the most common treatment approaches were the use of systemic steroids and antifibrotic drugs with a rate of 30.7% and 85.6%, respectively. The total median cost from the patient's admission to diagnosis was 540 Turkish Lira.
Conclusion: We believe that our findings compared with data from other countries will be useful in showing the current situation of ILD in our country to discuss this problem and making plans for a solution.
Keywords: Idiopathic Pulmonary Fibrosis; Interstitial Lung Disease; Lung.
Copyright: © 2021 SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES.
Conflict of interest statement
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.
Figures
References
-
- Morgenthau AS, Maria L, Padilla ML. Spectrum of Fibrosing Diffuse Parenchymal Lung Disease. Mount Sinai Journal of Medicine. 2009;76:2–23. - PubMed
-
- Dove EP, Olson AL, Glassberg MK. Trends in idiopathic pulmonary fibrosis-related mortality in the United States: 2000-2017. Am J RespirCritCareMed. 2019;200:929–931. - PubMed
-
- Fernandez Perez ER, Sprunger DB, Ratanawatkul P, Maier LA, Huie TJ, Swigris JJ, et al. Increasing hypersensitivity pneumonitis-related mortality in the United Statesfrom 1988 to 2016. Am J Respir Crit CareMed. 2019;199:1284–1287. - PubMed
-
- Travis WD, Costabel U, Hansell DM, et al. on behalf of the ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of theIdiopathic Interstitial Pneumonias. Am J Respir Crit Care Med. 2013;188:733–748. - PMC - PubMed
LinkOut - more resources
Full Text Sources